Ganglioside GQ1b, Tetrasialo, Tetraammonium Salt (CAS 68652-37-9)

Ganglioside GQ1b, a tetrasialo ganglioside, has emerged as a pivotal molecule in neuroscience research, particularly in elucidating its roles in neural development, synaptic function, and neurological disorders. GQ1b is predominantly expressed in the nervous system, where it plays crucial roles in modulating neuronal excitability and synaptic transmission. Research has unveiled its involvement in various cellular processes, including neurite outgrowth, synaptogenesis, and synaptic plasticity, suggesting its significance in shaping neural circuitry during development. Moreover, GQ1b has been implicated in the pathophysiology of neurological disorders, including Guillain-Barrε syndrome and Miller Fisher syndrome, where autoantibodies targeting GQ1b have been identified, leading to peripheral nerve dysfunction and neuromuscular abnormalities. Mechanistically, GQ1b interacts with specific cell surface receptors and ion channels, influencing intracellular signaling cascades and synaptic vesicle release machinery, thereby modulating neurotransmitter release and neuronal excitability. Recent studies have also highlighted its potential as a biomarker for neurological diseases and as a target for interventions aimed at modulating synaptic function and neuroprotection. Understanding the complex mechanisms underlying GQ1b′s functions in neural physiology and pathology holds promise for unraveling novel strategies for neurological disorders and advancing our knowledge of brain function.